Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers

Clinical trial NCT02849977 · COMPLETED

Trial details

NCT number: NCT02849977
Sponsor: Rhythm Pharmaceuticals, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations

Start date: 2016-09-28
Primary completion: 2020-06-09
Enrollment: 5966

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.